Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7785816 Antibodies against cancer antigen TMEFF2 and uses thereof

Patent 7785816 was granted and assigned to Facet Biotech on August, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Facet Biotech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77858160

Patent Inventor Names

Vinay Bhaskar0

Ingrid Caras0

Richard Murray0

Vanitha Ramakrishnan0

Agustin de la Calle0

Daniel Afar0

David Powers0

Debbie Law0

Date of Patent

August 31, 2010

Patent Application Number

118373330

Date Filed

August 10, 2007

Patent Primary Examiner

‌

Stephen L. Rawlings

Patent abstract

Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7785816 Antibodies against cancer antigen TMEFF2 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API